839.99 USD
-0.96 (-0.11%)
839.99 USD
0 (0%)
ARGX gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 530 industry peers in the Biotechnology industry. ARGX has an excellent financial health rating, but there are some minor concerns on its profitability. ARGX is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! This makes ARGX very considerable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year ARGX was profitable.
ARGX had a positive operating cash flow in the past year.
In the past 5 years ARGX reported 4 times negative net income.
ARGX had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 17.84%, ARGX belongs to the best of the industry, outperforming 96.42% of the companies in the same industry.
ARGX's Return On Equity of 21.00% is amongst the best of the industry. ARGX outperforms 96.23% of its industry peers.
With an excellent Return On Invested Capital value of 6.01%, ARGX belongs to the best of the industry, outperforming 92.08% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.84% | ||
| ROE | 21% | ||
| ROIC | 6.01% |
ROA(3y)-5.23%
ROA(5y)-11.34%
ROE(3y)-5.76%
ROE(5y)-13.95%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 41.97%, ARGX belongs to the top of the industry, outperforming 97.36% of the companies in the same industry.
The Operating Margin of ARGX (15.30%) is better than 93.21% of its industry peers.
ARGX's Gross Margin of 89.40% is amongst the best of the industry. ARGX outperforms 91.70% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.3% | ||
| PM (TTM) | 41.97% | ||
| GM | 89.4% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ARGX is destroying value.
The number of shares outstanding for ARGX has been increased compared to 1 year ago.
ARGX has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ARGX is higher compared to a year ago.
2.2 Solvency
ARGX has an Altman-Z score of 30.16. This indicates that ARGX is financially healthy and has little risk of bankruptcy at the moment.
ARGX's Altman-Z score of 30.16 is amongst the best of the industry. ARGX outperforms 93.21% of its industry peers.
ARGX has a debt to FCF ratio of 0.14. This is a very positive value and a sign of high solvency as it would only need 0.14 years to pay back of all of its debts.
The Debt to FCF ratio of ARGX (0.14) is better than 95.66% of its industry peers.
ARGX has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
ARGX has a Debt to Equity ratio of 0.01. This is comparable to the rest of the industry: ARGX outperforms 46.60% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.14 | ||
| Altman-Z | 30.16 |
ROIC/WACC0.81
WACC7.43%
2.3 Liquidity
A Current Ratio of 5.60 indicates that ARGX has no problem at all paying its short term obligations.
ARGX has a Current ratio of 5.60. This is comparable to the rest of the industry: ARGX outperforms 59.25% of its industry peers.
A Quick Ratio of 5.27 indicates that ARGX has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 5.27, ARGX is in line with its industry, outperforming 59.81% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.6 | ||
| Quick Ratio | 5.27 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 1512.50% over the past year.
Looking at the last year, ARGX shows a very strong growth in Revenue. The Revenue has grown by 64.71%.
The Revenue has been growing by 94.61% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)1512.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%272.66%
Revenue 1Y (TTM)64.71%
Revenue growth 3Y63.92%
Revenue growth 5Y94.61%
Sales Q2Q%95.51%
3.2 Future
The Earnings Per Share is expected to grow by 107.34% on average over the next years. This is a very strong growth
ARGX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 34.98% yearly.
EPS Next Y935.48%
EPS Next 2Y313.05%
EPS Next 3Y178.04%
EPS Next 5Y107.34%
Revenue Next Year95.19%
Revenue Next 2Y63.47%
Revenue Next 3Y48.27%
Revenue Next 5Y34.98%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 62.64, the valuation of ARGX can be described as expensive.
90.19% of the companies in the same industry are more expensive than ARGX, based on the Price/Earnings ratio.
ARGX's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.60.
ARGX is valuated quite expensively with a Price/Forward Earnings ratio of 26.37.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ARGX indicates a rather cheap valuation: ARGX is cheaper than 92.64% of the companies listed in the same industry.
ARGX is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.23, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 62.64 | ||
| Fwd PE | 26.37 |
4.2 Price Multiples
89.81% of the companies in the same industry are more expensive than ARGX, based on the Enterprise Value to EBITDA ratio.
91.13% of the companies in the same industry are more expensive than ARGX, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 167.52 | ||
| EV/EBITDA | 94.08 |
4.3 Compensation for Growth
ARGX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ARGX's earnings are expected to grow with 178.04% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.07
PEG (5Y)N/A
EPS Next 2Y313.05%
EPS Next 3Y178.04%
5. Dividend
5.1 Amount
No dividends for ARGX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
839.99
-0.96 (-0.11%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners43.42%
Inst Owner Change0%
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap51.72B
Revenue(TTM)3.60B
Net Income(TTM)1.28B
Analysts83.2
Price Target972.7 (15.8%)
Short Float %3.05%
Short Ratio5.47
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.16%
Min EPS beat(2)7.11%
Max EPS beat(2)23.2%
EPS beat(4)3
Avg EPS beat(4)3962.36%
Min EPS beat(4)-38.07%
Max EPS beat(4)15857.2%
EPS beat(8)5
Avg EPS beat(8)1996.71%
EPS beat(12)8
Avg EPS beat(12)1343.38%
EPS beat(16)12
Avg EPS beat(16)1012.62%
Revenue beat(2)1
Avg Revenue beat(2)3.68%
Min Revenue beat(2)-0.81%
Max Revenue beat(2)8.17%
Revenue beat(4)3
Avg Revenue beat(4)5.02%
Min Revenue beat(4)-0.81%
Max Revenue beat(4)8.17%
Revenue beat(8)6
Avg Revenue beat(8)5.96%
Revenue beat(12)10
Avg Revenue beat(12)14.45%
Revenue beat(16)13
Avg Revenue beat(16)17.87%
PT rev (1m)0.99%
PT rev (3m)13.99%
EPS NQ rev (1m)0.26%
EPS NQ rev (3m)0.72%
EPS NY rev (1m)-0.42%
EPS NY rev (3m)15.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.56%
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)5.34%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 62.64 | ||
| Fwd PE | 26.37 | ||
| P/S | 16.95 | ||
| P/FCF | 167.52 | ||
| P/OCF | 128.09 | ||
| P/B | 8.48 | ||
| P/tB | 8.8 | ||
| EV/EBITDA | 94.08 |
EPS(TTM)13.41
EY1.6%
EPS(NY)31.85
Fwd EY3.79%
FCF(TTM)5.01
FCFY0.6%
OCF(TTM)6.56
OCFY0.78%
SpS49.55
BVpS99.01
TBVpS95.45
PEG (NY)0.07
PEG (5Y)N/A
Graham Number172.84
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.84% | ||
| ROE | 21% | ||
| ROCE | 7.61% | ||
| ROIC | 6.01% | ||
| ROICexc | 16.72% | ||
| ROICexgc | 18.56% | ||
| OM | 15.3% | ||
| PM (TTM) | 41.97% | ||
| GM | 89.4% | ||
| FCFM | 10.12% |
ROA(3y)-5.23%
ROA(5y)-11.34%
ROE(3y)-5.76%
ROE(5y)-13.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.14 | ||
| Debt/EBITDA | 0.07 | ||
| Cap/Depr | 428.74% | ||
| Cap/Sales | 3.12% | ||
| Interest Coverage | 519.07 | ||
| Cash Conversion | 82.6% | ||
| Profit Quality | 24.11% | ||
| Current Ratio | 5.6 | ||
| Quick Ratio | 5.27 | ||
| Altman-Z | 30.16 |
F-Score6
WACC7.43%
ROIC/WACC0.81
Cap/Depr(3y)176.19%
Cap/Depr(5y)545.91%
Cap/Sales(3y)10.66%
Cap/Sales(5y)13.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1512.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%272.66%
EPS Next Y935.48%
EPS Next 2Y313.05%
EPS Next 3Y178.04%
EPS Next 5Y107.34%
Revenue 1Y (TTM)64.71%
Revenue growth 3Y63.92%
Revenue growth 5Y94.61%
Sales Q2Q%95.51%
Revenue Next Year95.19%
Revenue Next 2Y63.47%
Revenue Next 3Y48.27%
Revenue Next 5Y34.98%
EBIT growth 1Y208.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1529.77%
EBIT Next 3Y219.36%
EBIT Next 5Y122.64%
FCF growth 1Y140.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y161.76%
OCF growth 3YN/A
OCF growth 5YN/A
ARGENX SE - ADR / ARGX FAQ
What is the fundamental rating for ARGX stock?
ChartMill assigns a fundamental rating of 6 / 10 to ARGX.
What is the valuation status for ARGX stock?
ChartMill assigns a valuation rating of 6 / 10 to ARGENX SE - ADR (ARGX). This can be considered as Fairly Valued.
Can you provide the profitability details for ARGENX SE - ADR?
ARGENX SE - ADR (ARGX) has a profitability rating of 5 / 10.
What are the PE and PB ratios of ARGENX SE - ADR (ARGX) stock?
The Price/Earnings (PE) ratio for ARGENX SE - ADR (ARGX) is 62.64 and the Price/Book (PB) ratio is 8.48.
What is the earnings growth outlook for ARGENX SE - ADR?
The Earnings per Share (EPS) of ARGENX SE - ADR (ARGX) is expected to grow by 935.48% in the next year.